Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
23.08 USD | +3.10% | +4.45% | -36.76% |
05-09 | RBC Cuts Price Target on Prothena to $28 From $35, Keeps Sector Perform, Speculative Risk | MT |
05-08 | Earnings Flash (PRTA) PROTHENA CORPORATION Posts Q1 Revenue $50,000 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.76% | 1.2B | |
+7.67% | 113B | |
+10.98% | 106B | |
+0.41% | 22.27B | |
-11.88% | 22.22B | |
-5.99% | 19.43B | |
-37.36% | 17.87B | |
-5.87% | 17.24B | |
+6.87% | 14.29B | |
+36.11% | 12.52B |
- Stock Market
- Equities
- PRTA Stock
- News Prothena Corporation plc
- Prothena Says Phase 3 Trial Data Showed Survival Benefit in People With AL Amyloidosis Treated With Birtamimab